CurrentEndo coverage · page 3 of 12

Diabetes Technology & Therapeutics

Briefs 81–120 of 475 CurrentEndo has covered from this journal, newest publication first

Latest from Diabetes Technology & Therapeutics

All coverage, newest first

Diabetes Technol Ther5 Feb 2026
Automated Insulin Delivery Reduces the Risk of Diabetic Retinopathy in Adults with Type 1 Diabetes: A Prospective Cohort Study
Cohort studyTechnology
Diabetes Technol Ther5 Feb 2026
Glycemic Outcomes Following a Missed Premeal Bolus: A Comparative Study of Three Automated Insulin Delivery Systems in Children with Type 1 Diabetes
Cohort studyTechnology
Diabetes Technol Ther5 Feb 2026
MiniMed TM 780G Hybrid Closed-Loop Systems Improves Markers of Vascular and Endothelial Function in Patients with Type 1 Diabetes: Association with Continuous Glucose Monitoring Metrics
Cohort studyTechnology
Diabetes Technol Ther5 Feb 2026
Recommendations from the United Kingdom UNBIASED Study to Address Diabetes Technology Access Disparities for Children and Young People
Research articleT1D
Diabetes Technol Ther4 Feb 2026
Association of Time in Tight Range with Microvascular Complications in Japanese Patients with Type 2 Diabetes Mellitus: A Multicenter Cross-Sectional Study
Cross-sectional studyComplications
Diabetes Technol Ther4 Feb 2026
Efficacy and Safety of Oral GLP-1 RA Orforglipron on Weight and Glycemic Control According to Diabetes Status: A Systematic Review and Meta-Analysis
Meta-analysisObesity
Diabetes Technol Ther4 Feb 2026
Efficacy and Safety of Dipeptidyl Peptidase-4 Inhibitors, Glucagon-Like Peptide-1 Receptor Agonists, and Sodium–Glucose Cotransporter-2 Inhibitors as Adjunctive Therapy to Automated Insulin Delivery System in Type 1 Diabetes: A Systematic Review and Meta-Analysis of Randomized Clinical Trials
Meta-analysisTechnology
Diabetes Technol Ther4 Feb 2026
Inhaled Technosphere Insulin in Children with Diabetes: The INHALE-1 Extension Study
Randomized controlled trialTechnology
Diabetes Technol Ther23 Jan 2026
Real-World Incidence of Lung Malignancy and Chronic Obstructive Pulmonary Disease with Inhaled Insulin in People with Diabetes
Cohort studyT2D & other
Diabetes Technol Ther23 Jan 2026
The Effect of Automated Insulin Delivery Systems on Sleep Quality and Quantity in Type 1 Diabetes: A Systematic Review and Meta-Analysis
Meta-analysisTechnology
Diabetes Technol Ther23 Jan 2026
Diagnostic Accuracy of Artificial Intelligence-Enabled Retinal Biomarkers for Detecting Type 2 Diabetes and Prediabetes Among Asian Indians [DART Study]
Diagnostic or prognostic studyT2D & other
Diabetes Technol Ther23 Jan 2026
Association of Continuous Glucose Monitoring Metrics with Incident Diabetic Retinopathy: A Real-World Long-Term Study
Cohort studyTechnology
Diabetes Technol Ther23 Jan 2026
Consistent Benefit of Control-IQ+ Automated Insulin Delivery Across a Range of Characteristics of Adults with Type 2 Diabetes
Secondary analysisTechnology
Diabetes Technol Ther23 Jan 2026
Performance of the Fifth Generation of a 16-Day Continuous Glucose Monitoring System in Adults with Diabetes
Diagnostic or prognostic studyTechnology
Diabetes Technol Ther23 Jan 2026
Automated Insulin Delivery Associated with Superior Glycemic Outcomes in Type 1 Diabetes: A Swedish National Registry Analysis
Cohort studyTechnology
Diabetes Technol Ther23 Jan 2026
Accuracy of Dexcom One+ in Patients with Diabetes or Stress Hyperglycemia Hospitalized in Cardiac Intensive Care Unit
Diagnostic or prognostic studyTechnology
Diabetes Technol Ther23 Jan 2026
Overcoming Closed-Loop System Limits: Diluted Insulin Improves Glycemic Control and Reduces Nighttime Hypoglycemia in Toddlers with Low Insulin Requirements
Cohort studyTechnology
Diabetes Technol Ther23 Jan 2026
Clinical Impact of Continuous Glucose Monitoring in Noninsulin Treated Type 2 Diabetes: A Review
Randomized controlled trialTechnology
Diabetes Technol Ther23 Jan 2026
Outcomes in United States Veterans on Insulin Pumps Following Rapid Deployment of Telehealth Care
Cohort studyTechnology
Diabetes Technol Ther23 Jan 2026
Hybrid Closed-Loop Disconnection Reduces the Risk of Hypoglycemia in Active Children and Adolescents with Type 1 Diabetes: A Randomized Controlled Pilot Study
Randomized controlled trialTechnology
Diabetes Technol Ther21 Jan 2026
A Real-World Data Assessment of Pulmonary Toxicity of Inhaled Insulin for Diabetes
Cohort studyT2D & other
Diabetes Technol Ther21 Jan 2026
Glycemic Outcomes with an Open-Source Automated Insulin Delivery System in Adults with Type 1 Diabetes: A 1-Year Real-World Observational Study
Cohort studyTechnology
Diabetes Technol Ther15 Jan 2026
Transient Benign Ketosis Is Common in Type 1 Diabetes During Very-Low Carbohydrate States: Novel Data from Continuous Ketone Sensor
Randomized controlled trialT1D
Diabetes Technol Ther12 Jan 2026
Budget Impact of Advanced Insulin Delivery Systems for the Management of Type 1 Diabetes
Cohort studyTechnology
Diabetes Technol Ther1 Jan 2026
All-Cause Mortality and Health Care Resource Utilization in Patients with Type 1 Diabetes Treated with Glucagon-like Peptide 1 Receptor Agonists/Glucose-Dependent Insulinotropic Polypeptide
Cohort study
Diabetes Technol Ther24 Dec 2025
Continuous Glucose Monitoring and Hypoglycemia Detection while Driving: Results from a Cross-Sectional Survey
Cross-sectional studyTechnology
Diabetes Technol Ther22 Dec 2025
An Exploratory Analysis of Continuous Glucose Monitoring Metrics in Relation to Prediabetes in Youths with Obesity
Cross-sectional study
Diabetes Technol Ther22 Dec 2025
Cost–Utility Analysis of Control-IQ Technology Relative to Conventional Insulin Therapy in Adults with Type 1 Diabetes
Cohort studyTechnology
Diabetes Technol Ther22 Dec 2025
Twenty-Five Hours of Fasting with Automated Insulin Delivery in Youth with Type 1 Diabetes
Research articleTechnology
Diabetes Technol Ther15 Dec 2025
Differences Between Glycemia Estimates from Hemoglobin A1c and Continuous Glucose Monitoring and Their Association with Complete Blood Counts
Secondary analysisTechnology
Diabetes Technol Ther11 Dec 2025
Time in Tight Range Versus Time in Range for Predicting Diabetic Retinopathy in Adults with Type 1 Diabetes Using Multiple Daily Insulin Injections: A Retrospective Longitudinal Study with isCGM Data
Cohort studyComplications
Diabetes Technol Ther3 Dec 2025
The Impact of Continuous Glucose Monitoring Use Versus Nonuse on Clinical and Economic Outcomes in Individuals Using Rapid- and Short-Acting Insulin: A Retrospective Analysis
Cohort studyTechnology
Diabetes Technol Ther3 Dec 2025
Variation in Hypoglycemia Risk During Real-World Physical Activity in Adults with Type 1 Diabetes: Insights from the Type 1 Diabetes Exercise Initiative
Cohort studyT1D
Diabetes Technol Ther21 Nov 2025
Monitoring Ketonemia in People with Diabetes: Preliminary Findings from Real-World Studies
Research articleComplications
Diabetes Technol Ther20 Nov 2025
Normal Reference Range for Glucose Rates of Change in Nondiabetic Individuals Using Continuous Glucose Monitoring
Research articleTechnology
Diabetes Technol Ther20 Nov 2025
A Phase 2 (2a) Randomized Trial of Iscalimab in Adolescents and Young Adults with New-Onset Type 1 Diabetes
Randomized controlled trialT1D
Diabetes Technol Ther20 Nov 2025
Real-World HbA1c Following Initiation of the Omnipod 5 Automated Insulin Delivery System
Cohort studyTechnology
Diabetes Technol Ther19 Nov 2025
Glucose Responses to Aerobic Exercise Are Influenced by Glucose Levels before the Exercise and Menstrual Cycle Phase in Adults with Type 1 Diabetes on Multiple Daily Insulin Injections
Secondary analysisT1D
Diabetes Technol Ther19 Nov 2025
Multivendor Continuous Glucose Monitor Integration into the Electronic Health Record: Real-World Experience of an Academic Pediatric Endocrinology Clinic
Research articleTechnology
Diabetes Technol Ther14 Nov 2025
Mitigation Strategies for a Missed Meal Bolus in People with Type 1 Diabetes Using the Minimed ™ 780G System
Cohort studyTechnology

All 475 Briefs in ExploreShowing Briefs 81–120 of 475, newest first